They want your GENOME – Europe goes first

ER Editor: We do recommend taking a look at this EU Commission page titled 1+ Million Genomes Initiative, linked to below. After injecting potentially billions of us with a DNA-altering injection, producing millions of dead and even more seriously injured, you are simply left shaking your head. Think: US biolabs in Ukraine (and elsewhere), linked to the Covid shots allegedly, possibly targeting the genetic code of various groups.

Some takeaways:

The 1+ Million Genomes initiative has the potential to improve disease prevention [CAUSATION?], allow for more personalised treatments and support groundbreaking research.


The ‘1+ Million Genomes’ (1+MG) initiative aims to enable secure access to genomics and the corresponding clinical data across Europe for better research, personalised healthcare and health policy making. Since the Digital Day 2018, 25 EU countries, the UK and Norway signed Member States’ declaration on stepping up efforts towards creating a European data infrastructure for genomic data and implementing common national rules enabling federated data access. The initiative forms part of the EU’s agenda for the Digital Transformation of Health and Care and is aligned with the goals of the European Health Data Space.

Genome of Europe

The Genome of Europe is a multi-country project designed and coordinated with the support of B1MG. It brings together European countries to build a high-quality European network of national genomic reference cohorts, representative of the European population. 

All countries involved generate via whole genome sequencing a national genomic reference dataset based on their own national population cohort, all according to jointly established ‘1+MG-proof’ guidelines. Each country’s dataset will form a unique national reference collection in its own right. The collection will benefit national personalised healthcare and prevention strategies.

Collectively, crosslinked via the 1+MG initiative, the national collections will establish a world-class European reference data resource (The Genome of Europe) for research and innovation of healthcare.

This page indicates that this project has been quietly ongoing since 2018 (at least). Did any of us know?

Perhaps the PCR tests hadn’t scooped up enough of our DNA.

Dr. Meryl Nass below picks up on a few more juicy points from this page.


They want your GENOME. Europe goes first, in its 1+ Million Genomes project, launched in 2018. This is why the WHO demands each country build a genomics sequencing lab

They want a Brave New World and they want it NOW. Test-tube babies, anyone?


What are the Signatories trying to achieve?

The Signatory countries have various objectives. Among these, are:

  • ensuring that appropriate technical infrastructure is available across the EU, allowing for secure, federated access to genomic data;
  • making sure that ethical and legal implications of genomics are clear and taken into account;
  • ensuring that the general public and policy makers in Member States and signatory countries are well informed about genomics, in order to ensure its uptake by healthcare systems and integration into personalised healthcare.

The EU as a global player in genomics

We live in an era where genomics becomes increasingly important globally. The European Union’s genomic collaboration and research have to be citizen-focused and patient-friendly. It should make sure that the highest standards are applied for the usage, access and storage of genomic data. 1+MG is one of world’s biggest projects of this kind and contributes chiefly to setting global standards in this domain. The connection to the European Health Data Space will provide an additional boost to the information potential benefitting researchers, healthcare professionals and all citizens, eventually.

The EU wants everyone’s genome, but are starting with 1 million plus European citizens. While it is true that there could be great medical benefits for individuals in terms of ‘personalized medicine’ I can assure you that so far those benefits have failed to materialize, except in rare cases of cancer treatment.

The powers that be want access to your genome and they want to share it (for a fee?) and make money from patenting your genes, if you have any that confer special benefits. Applying the handwaving “highest standards” lingo when we are talking about your most personal possession is another way of saying that privacy is being ignored. They also plan to link your genome to your health records.

I have been saying that the IHR amendments and newest “Bureau Text” of the WHO pandemic treaty both require nations to build genomics labs and perform sequencing. While at first glance it seems they might just want to sequence viruses found in the wild—this EU project tells you what the desire for a world-wide sequencing project is really about.

This could be the ultimate form of control, by capitalizing on genetic weaknesses (as well as patenting strengths), which you probably did not even know you had.

In my book this is as dastardly as it gets.

Naturally, the Wellcome Trust has its grubby fingers in this pie, along with Big Pharma. Who do you think this is really going to help? The COVID vaccines should have made clear that governments, big philanthropy (especially Wellcome) and big pharma do not have our best interests at heart. Public-private partnership means spending public money on private goods. Often coupled with a liability waiver. In 2023 it means corruption.

This dataset represents the world’s largest single release of WGS data[2]. When combined with the extensive amount of lifestyle, biochemical, imaging and health outcome data already held for UK Biobank participants, it will enable researchers to better understand the role of genetics for health outcomes and to advance drug discovery and development.

The whole genome sequencing (WGS) of all 500,000 UK Biobank participants is the most ambitious project of its kind ever undertaken. It has been funded through a public-private partnership involving Amgen, AstraZeneca, GlaxoSmithKline (GSK) and Johnson & Johnson[3], alongside Wellcome and UK Research and Innovation (UKRI), and sequencing has been carried out by deCODE Genetics and the Wellcome Sanger Institute[4]. The release of these 200,000 whole genomes today will be followed up by the release of the WGS data for the remaining 300,000 participants in early 2023.




The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)


Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.


Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.


Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.

1 Comment on They want your GENOME – Europe goes first

  1. Participation in genetic origin sites like 23 and me and Ancestry could wind up in these data banks.
    Perhaps that the reason they were developed. They seem to be quite popular but at what cost ultimately?

Leave a Reply

Your email address will not be published.